216 related articles for article (PubMed ID: 24188815)
1. Magnetization transfer contrast imaging reveals amyloid pathology in Alzheimer's disease transgenic mice.
Bigot C; Vanhoutte G; Verhoye M; Van der Linden A
Neuroimage; 2014 Feb; 87():111-9. PubMed ID: 24188815
[TBL] [Abstract][Full Text] [Related]
2. Detection of Aβ plaques by a novel specific MRI probe precursor CR-BSA-(Gd-DTPA)n in APP/PS1 transgenic mice.
Li S; He H; Cui W; Gu B; Li J; Qi Z; Zhou G; Liang CM; Feng XY
Anat Rec (Hoboken); 2010 Dec; 293(12):2136-43. PubMed ID: 21089051
[TBL] [Abstract][Full Text] [Related]
3. Gadolinium-staining reveals amyloid plaques in the brain of Alzheimer's transgenic mice.
Petiet A; Santin M; Bertrand A; Wiggins CJ; Petit F; Houitte D; Hantraye P; Benavides J; Debeir T; Rooney T; Dhenain M
Neurobiol Aging; 2012 Aug; 33(8):1533-44. PubMed ID: 21531045
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
[TBL] [Abstract][Full Text] [Related]
5. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging.
Wadghiri YZ; Sigurdsson EM; Sadowski M; Elliott JI; Li Y; Scholtzova H; Tang CY; Aguinaldo G; Pappolla M; Duff K; Wisniewski T; Turnbull DH
Magn Reson Med; 2003 Aug; 50(2):293-302. PubMed ID: 12876705
[TBL] [Abstract][Full Text] [Related]
6. Early cortical thickness changes predict β-amyloid deposition in a mouse model of Alzheimer's disease.
Grand'maison M; Zehntner SP; Ho MK; Hébert F; Wood A; Carbonell F; Zijdenbos AP; Hamel E; Bedell BJ
Neurobiol Dis; 2013 Jun; 54():59-67. PubMed ID: 23454197
[TBL] [Abstract][Full Text] [Related]
7. Use of magnetization transfer contrast MRI to detect early molecular pathology in Alzheimer's disease.
Pérez-Torres CJ; Reynolds JO; Pautler RG
Magn Reson Med; 2014 Jan; 71(1):333-8. PubMed ID: 23413044
[TBL] [Abstract][Full Text] [Related]
8. MRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice.
Meadowcroft MD; Connor JR; Smith MB; Yang QX
J Magn Reson Imaging; 2009 May; 29(5):997-1007. PubMed ID: 19388095
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance T2 relaxation time at 7 Tesla associated with amyloid β pathology and age in a double-transgenic mouse model of Alzheimer's disease.
Li L; Wang XY; Gao FB; Wang L; Xia R; Li ZX; Xing W; Tang BS; Zeng Y; Zhou GF; Zhou HY; Liao WH
Neurosci Lett; 2016 Jan; 610():92-7. PubMed ID: 26520465
[TBL] [Abstract][Full Text] [Related]
10. Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease.
El Tannir El Tayara N; Delatour B; Le Cudennec C; Guégan M; Volk A; Dhenain M
Neurobiol Dis; 2006 Apr; 22(1):199-208. PubMed ID: 16337798
[TBL] [Abstract][Full Text] [Related]
11. In vivo measurement of plaque burden in a mouse model of Alzheimer's disease.
Borthakur A; Gur T; Wheaton AJ; Corbo M; Trojanowski JQ; Lee VM; Reddy R
J Magn Reson Imaging; 2006 Nov; 24(5):1011-7. PubMed ID: 17036339
[TBL] [Abstract][Full Text] [Related]
12. Quantitative MRI reveals aging-associated T2 changes in mouse models of Alzheimer's disease.
Falangola MF; Dyakin VV; Lee SP; Bogart A; Babb JS; Duff K; Nixon R; Helpern JA
NMR Biomed; 2007 May; 20(3):343-51. PubMed ID: 17451178
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP[V717I] transgenic mice, a model for Alzheimer's disease.
Vanhoutte G; Dewachter I; Borghgraef P; Van Leuven F; Van der Linden A
Magn Reson Med; 2005 Mar; 53(3):607-13. PubMed ID: 15723413
[TBL] [Abstract][Full Text] [Related]
14. Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease.
Schmitz C; Rutten BP; Pielen A; Schäfer S; Wirths O; Tremp G; Czech C; Blanchard V; Multhaup G; Rezaie P; Korr H; Steinbusch HW; Pradier L; Bayer TA
Am J Pathol; 2004 Apr; 164(4):1495-502. PubMed ID: 15039236
[TBL] [Abstract][Full Text] [Related]
15. Characterization of in vivo MRI detectable thalamic amyloid plaques from APP/PS1 mice.
Dhenain M; El Tannir El Tayara N; Wu TD; Guégan M; Volk A; Quintana C; Delatour B
Neurobiol Aging; 2009 Jan; 30(1):41-53. PubMed ID: 17588710
[TBL] [Abstract][Full Text] [Related]
16. Visualization of beta-amyloid plaques in a transgenic mouse model of Alzheimer's disease using MR microscopy without contrast reagents.
Lee SP; Falangola MF; Nixon RA; Duff K; Helpern JA
Magn Reson Med; 2004 Sep; 52(3):538-44. PubMed ID: 15334572
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
[TBL] [Abstract][Full Text] [Related]
18. Comparison of manual and semi-automated segmentation methods to evaluate hippocampus volume in APP and PS1 transgenic mice obtained via in vivo magnetic resonance imaging.
Hayes K; Buist R; Vincent TJ; Thiessen JD; Zhang Y; Zhang H; Wang J; Summers AR; Kong J; Li XM; Martin M
J Neurosci Methods; 2014 Jan; 221():103-11. PubMed ID: 24091139
[TBL] [Abstract][Full Text] [Related]
19. In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent.
Jack CR; Garwood M; Wengenack TM; Borowski B; Curran GL; Lin J; Adriany G; Gröhn OH; Grimm R; Poduslo JF
Magn Reson Med; 2004 Dec; 52(6):1263-71. PubMed ID: 15562496
[TBL] [Abstract][Full Text] [Related]
20. Fractal analysis of amyloid plaques in Alzheimer's disease patients and mouse models.
Pirici D; Van Cauwenberghe C; Van Broeckhoven C; Kumar-Singh S
Neurobiol Aging; 2011 Sep; 32(9):1579-87. PubMed ID: 20015575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
